| __timestamp | Alpine Immune Sciences, Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 180753000 |
| Thursday, January 1, 2015 | 16054000 | 224193000 |
| Friday, January 1, 2016 | 23316000 | 197617000 |
| Sunday, January 1, 2017 | 10626000 | 288320000 |
| Monday, January 1, 2018 | 28970000 | 240661000 |
| Tuesday, January 1, 2019 | 35847000 | 276018000 |
| Wednesday, January 1, 2020 | 27185000 | 294216000 |
| Friday, January 1, 2021 | 58742000 | 354881000 |
| Saturday, January 1, 2022 | 70243000 | 361140000 |
| Sunday, January 1, 2023 | 80904000 | 330551000 |
Unleashing insights
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Grifols, S.A. and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to R&D investment.
Grifols, a global leader in plasma-derived medicines, has consistently allocated substantial resources to R&D, with expenditures peaking at approximately 360 million in 2022. This represents a steady increase of around 100% from 2014, underscoring their dedication to advancing medical therapies.
Conversely, Alpine Immune Sciences, a smaller biotech firm, has shown a remarkable growth trajectory in R&D spending, surging by over 500% from 2014 to 2023. This rapid increase highlights their aggressive pursuit of novel immunotherapies.
These trends reflect the dynamic nature of the biotech industry, where strategic R&D investments can drive innovation and shape the future of healthcare.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Grifols, S.A.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Dr. Reddy's Laboratories Limited or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Grifols, S.A. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
Research and Development Investment: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.